T2	outcome-Measure 724 777	6-month percentage of 25OHD serum level normalization
T3	control 520 577	6-month conventional (C) vitD and calcium supplementation
T4	intervention 583 610	6-month high-dose oral vitD
T5	total-participants 790 793	215
T6	total-participants 867 870	195
T7	intervention-participants 900 903	100
T8	control-participants 908 910	95
T9	outcome 913 957	Compliance to the daily oral supplementation
T10	cv-bin-percent 962 967	68.4%
T11	iv-bin-percent 972 975	67%
T12	outcome 1011 1050	Discontinuous high-dose vitD compliance
T13	iv-bin-percent 1081 1084	77%
T15	iv-bin-percent 1167 1170	30%
T16	cv-bin-percent 1178 1183	12.6%
T17	outcome 1217 1231	well tolerated
T18	cv-bin-percent 1332 1341	Fifty-two
T19	outcome 1393 1414	switched to the T arm
T1	intervention 26 59	vitamin D supplementation regimen
T14	outcome 1131 1152	normalized vitD level
T20	outcome 1467 1494	achieved vitD normalization
